On-site bundled rapid HIV/HCV testing in substance use disorder treatment programs: study protocol for a hybrid design randomized controlled trial
Background More than 1.2 million people in the United States are living with human
immunodeficiency virus (HIV), and 3.2 million are living with hepatitis C virus (HCV). An …
immunodeficiency virus (HIV), and 3.2 million are living with hepatitis C virus (HCV). An …
New all oral therapy for chronic hepatitis C virus (HCV): a novel long-term cost comparison
JM Poonsapaya, M Einodshofer, HS Kirkham… - Cost Effectiveness and …, 2015 - Springer
Background In the US, the prevalence of hepatitis C virus (HCV) has surpassed the
prevalence of human immunodeficiency virus (HIV), with about 3.3 million people …
prevalence of human immunodeficiency virus (HIV), with about 3.3 million people …
Awareness of HCV infection among persons who inject drugs in San Diego, California
MG Collier, SK Bhaurla… - … journal of public …, 2015 - ajph.aphapublications.org
We asked persons who inject drugs questions about HCV, including past testing and
diagnosis followed by HCV testing. Of 540 participants, 145 (27%) were anti-HCV positive …
diagnosis followed by HCV testing. Of 540 participants, 145 (27%) were anti-HCV positive …
Substance use and hepatitis C: an ecological momentary assessment study.
KA Phillips, DH Epstein, M Vahabzadeh… - Health …, 2014 - psycnet.apa.org
Objective: The objective of this study was to assess craving and mood related to opioid and
cocaine use among asymptomatic hepatitis C virus (HCV)+ and HCV–methadone patients …
cocaine use among asymptomatic hepatitis C virus (HCV)+ and HCV–methadone patients …
Universal screening for hepatitis C—In for a penny, in for a pound
I Garrido, G Macedo - European Journal of Clinical Microbiology & …, 2022 - Springer
Infection with hepatitis C virus (HCV) is a major public health problem. In fact, chronic HCV is
a leading cause of cirrhosis, hepatocellular carcinoma, and death from liver disease in most …
a leading cause of cirrhosis, hepatocellular carcinoma, and death from liver disease in most …
DOES INFORMATION ABOUT IDUS'INJECTING NETWORKS PREDICT EXPOSURE TO THE HEPATITIS C VIRUS?
CK Aitken, JA Lewis, JS Hocking, DS Bowden… - 2009 - sid.ir
Abstract Background and Aims: Many previous studies have used cross-sectional
approaches to measure associations between INJECTING DRUG USERS'(IDUs') …
approaches to measure associations between INJECTING DRUG USERS'(IDUs') …
Estimated effect of US state syringe sale policy on source of last-used injection equipment
Background Many people who inject drugs (PWID) lack access to a new sterile syringe each
time they inject, with increased risk of injection-related harms, including spread of …
time they inject, with increased risk of injection-related harms, including spread of …
Injection partnership characteristics and HCV status associations with syringe and equipment sharing among people who inject drugs
Background Sharing of syringes is the leading transmission pathway for hepatitis C (HCV)
infections. The extent to which HCV can spread among people who inject drugs (PWID) is …
infections. The extent to which HCV can spread among people who inject drugs (PWID) is …
HIV and HCV discordant injecting partners and their association to drug equipment sharing
Our objective was to examine the association between HIV and HCV discordant infection
status and the sharing of drug equipment by injection drug users (IDUs). IDUs were recruited …
status and the sharing of drug equipment by injection drug users (IDUs). IDUs were recruited …
Hepatitis C among methadone maintenance treatment patients in Shanghai and Kunming, China
Y Hser, J Du, J Li, M Zhao, YJ Chang… - Journal of public …, 2012 - academic.oup.com
Background This study aims to:(1) document the prevalence of hepatitis C virus (HCV)
among methadone maintenance treatment (MMT) patients in Kunming and Shanghai;(2) …
among methadone maintenance treatment (MMT) patients in Kunming and Shanghai;(2) …